Ginkgo Bioworks Holdings (DNA) Tax Provisions (2020 - 2026)

Ginkgo Bioworks Holdings (DNA) has reported Tax Provisions for 7 consecutive years, with $128000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Tax Provisions rose 145.23% year-over-year to $128000.0; the trailing twelve-month figure through Jun 2026 stood at -$594000.0 (up 33.63% YoY), and the FY2025 full-year result was -$837000.0, down 74.74% from the prior year.
• Tax Provisions improved to $128000.0 in Q2 2026 per DNA's latest filing, from -$80000.0 in the prior quarter.
• Across five years, Tax Provisions topped out at $190000.0 in Q2 2024 and bottomed at -$14.8 million in Q4 2022.
• Historically, Tax Provisions has averaged -$909222.2 across 5 years, with a median of -$36500.0 in 2022.
• The sharpest annual moves came in 2022 and 2023: Tax Provisions plunged 2062.52% in 2022, then jumped 248.89% in 2023.
• Over 5 years, Tax Provisions stood at -$14.8 million in 2022, then jumped by 98.66% to -$198000.0 in 2023, then sank by 64.14% to -$325000.0 in 2024, then plunged by 97.85% to -$643000.0 in 2025, then surged by 119.91% to $128000.0 in 2026.
• According to Business Quant data, Tax Provisions over the past three periods registered $128000.0, -$80000.0, and -$643000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.